Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27700719 | 0.87 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL9545865 | 0.87 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL4967588 | 0.87 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL39118 | 0.87 | ALDH1A1 (0.70) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL1158413 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| Potassium SCHEMBL317509 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| Hydrochloric Acid SCHEMBL8612216 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL31285706 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL8445150 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 | |
| SCHEMBL317508 | 0.84 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057346-A | USED TO DELAY OR SUPPRESS THE TRANSITION OF A RETROVIRAL INFECTION FROM A LATENT TO A VIRULENT CONDITION, THEREBY AMELIORATING RETROVIRALLY CAUSED DISEASES SUCH AS AIDS, ARE ALSO USEFUL IN CANCER TREATMENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0797438-A1 | INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-10-01 | — | — | EP | disclosed |
| WO-1996018394-A1 | INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OFHEALTH AND HUMAN SERVICES (US) | 1996-06-20 | — | — | WO | disclosed |
| WO-1995007695-A1 | METHOD FOR INHIBITING METALLOPROTEINASE EXPRESSION | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-23 | — | — | WO | disclosed |